← FDA DRUG APPROVALS

FDA ANDA · ANDA062142

DOXYCYCLINE HYCLATE

Sponsor: WATSON LABS

APPLICATION
ANDA062142
TYPE
ANDA
ORIGINAL APPROVAL
1981-08-12
LATEST ACTION
1998-07-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 100MG BASE · CAPSULE · ORAL
DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 50MG BASE · CAPSULE · ORAL

Approval history

1998-07-17Manufacturing (CMC) · Supplement 25AP
1997-05-23Manufacturing (CMC) · Supplement 24AP
1997-01-31Manufacturing (CMC) · Supplement 23AP
1994-01-11Labeling · Supplement 22AP
1993-07-14Labeling · Supplement 21AP
1992-08-24Labeling · Supplement 19AP
1992-08-24Labeling · Supplement 20AP
1992-05-13Labeling · Supplement 18AP
1988-06-22Manufacturing (CMC) · Supplement 17AP
1981-08-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →